A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

Clinical trial NCT07268638 · RECRUITING

Trial details

NCT number: NCT07268638
Sponsor: Akebia Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Focal Segmental Glomerulosclerosis

Start date: 2025-12-03
Primary completion: 2027-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.